Tumour escape from immune surveillance through dendritic cell inactivation - PubMed (original) (raw)

Review

Tumour escape from immune surveillance through dendritic cell inactivation

Alain P Vicari et al. Semin Cancer Biol. 2002 Feb.

Abstract

Dendritic cells (DC) are central to the initiation of immunity. To induce immune reactivity, DC are recruited at the site of antigen expression, uptake antigens and migrate to secondary lymphoid organs while receiving activation signals delivered by pathogens, dying cells, and/or T cells. Tumours can escape the immune system by interfering with the migration of DC or by not providing the necessary activation signals. Moreover, tumours promote the secretion of factors that inhibit DC differentiation and functions. We will review the current knowledge of the physiopathology of DC in cancer, which paves the way for novel strategies of therapeutic intervention.

PubMed Disclaimer

Similar articles

• Tumor-host immune interactions and dendritic cell dysfunction.
  Yang L, Carbone DP. Yang L, et al. Adv Cancer Res. 2004;92:13-27. doi: 10.1016/S0065-230X(04)92002-7. Adv Cancer Res. 2004. PMID: 15530555 Review.
• Immune regulation by dendritic cells and T cells--basic science, diagnostic, and clinical application.
  Tuettenberg A, Becker C, Correll A, Steinbrink K, Jonuleit H. Tuettenberg A, et al. Clin Lab. 2011;57(1-2):1-12. Clin Lab. 2011. PMID: 21391459 Review.
• Dendritic cells from bench to bedside and back.
  Adema GJ. Adema GJ. Immunol Lett. 2009 Feb 21;122(2):128-30. doi: 10.1016/j.imlet.2008.11.017. Epub 2008 Dec 31. Immunol Lett. 2009. PMID: 19121337 Review.
• Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
  Steinbrink K, Mahnke K, Grabbe S, Enk AH, Jonuleit H. Steinbrink K, et al. Hum Immunol. 2009 May;70(5):289-93. doi: 10.1016/j.humimm.2009.02.003. Epub 2009 Feb 13. Hum Immunol. 2009. PMID: 19217922 Review.
• The dendritic cell system and anti-tumour immunity.
  Austyn JM. Austyn JM. In Vivo. 1993 May-Jun;7(3):193-201. In Vivo. 1993. PMID: 8357961 Review.

Cited by

• Improving targeted small molecule drugs to overcome chemotherapy resistance.
  Rismanbaf A. Rismanbaf A. Cancer Rep (Hoboken). 2024 Jan;7(1):e1945. doi: 10.1002/cnr2.1945. Epub 2023 Nov 22. Cancer Rep (Hoboken). 2024. PMID: 37994401 Free PMC article. Review.
• Promoting effect of Antrodia camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine.
  Huang CH, Chang CC, Lin CM, Wang ST, Wu MT, Li EI, Chang HC, Lin CC. Huang CH, et al. Cancer Immunol Immunother. 2010 Aug;59(8):1259-72. doi: 10.1007/s00262-010-0852-y. Cancer Immunol Immunother. 2010. PMID: 20390417 Free PMC article.
• Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer.
  Yan BM, Van Dam J. Yan BM, et al. Can J Gastroenterol. 2008 Apr;22(4):405-10. doi: 10.1155/2008/104398. Can J Gastroenterol. 2008. PMID: 18414717 Free PMC article. Review.
• Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.
  Stewart CA, Metheny H, Iida N, Smith L, Hanson M, Steinhagen F, Leighty RM, Roers A, Karp CL, Müller W, Trinchieri G. Stewart CA, et al. J Clin Invest. 2013 Nov;123(11):4859-74. doi: 10.1172/JCI65180. J Clin Invest. 2013. PMID: 24216477 Free PMC article.
• Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies.
  Fanelli GN, Grassini D, Ortenzi V, Pasqualetti F, Montemurro N, Perrini P, Naccarato AG, Scatena C. Fanelli GN, et al. Genes (Basel). 2021 Mar 20;12(3):445. doi: 10.3390/genes12030445. Genes (Basel). 2021. PMID: 33804731 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database